cidofovir anhydrous has been researched along with Hodgkin Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldelli, F; De Socio, GV; Minga, P; Rosignoli, D; Simonetti, S; Tomassini, GM | 1 |
Abdelhalim, A; Almyroudis, NG; Battiwalla, M; Becker, J; Elefante, A; McCarthy, A; McCarthy, PL; Paplham, P; Segal, BH; Smith, P | 1 |
2 other study(ies) available for cidofovir anhydrous and Hodgkin Disease
Article | Year |
---|---|
Topical cidofovir for severe warts in a patient affected by AIDS and Hodgkin's lymphoma.
Topics: Administration, Topical; Adult; Antiviral Agents; Cidofovir; Cytosine; Foot; Hand; HIV Infections; Hodgkin Disease; Human papillomavirus 16; Humans; Lymphoma, AIDS-Related; Male; Organophosphonates; Papillomaviridae; Treatment Outcome; Warts | 2008 |
Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Therapy, Combination; Encephalitis, Viral; Fatal Outcome; Ganciclovir; Hodgkin Disease; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Organophosphonates; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Renal Insufficiency; Secondary Prevention; Treatment Failure; Virus Activation | 2007 |